| Encyclopaedia |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Writing and Speaking > Story Structure - The Antagonism |
|
Encyclopaedia - Story Structure - The Antagonism
The Hero’s Journey is the template upon which the vast majority of successful stories and Hollywood blockbu According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product sters are based upon. Understanding this template is a priority for story or screenwriters. The Hero’s Jou ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ney: • Attempts to tap into unconscious expectations the audience has regarding what a story is and how it lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. should be told. • Gives the writer more structural elements than simply three or four acts, plot points, here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe id point and so on. • Interpreted metaphorically, laterally and symbolically, allows an infinite number of d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro varied stories to be created. By understanding exactly what elements make up each major stage of the Hero ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s Journey, screenwriters can easily build a screenplay from the ground up. A critical element of the Call easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to Adventure is the Antagonism. The story and editing determine where and how the antagonism is introduced, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically but it is rare to find not a mention of it during this stage of the journey: In Star Wars (1977), the firs and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t sequence introduces the antagonism (Vader) and the need for a resolution. Often, the antagonism is refer ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nced if not actually introduced: In Dances with Wolves (Academy Award Winner Best Film, 1990), the Pawnee ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a and the White Man are not developed as antagonists until a much later stage. But the White Man as antagonis dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod is referenced early on (“the Indians are nothing but thieves and beggars.”) And sometimes the antagonism cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin is simply a tool to help with the hero’s other challenges: In Million Dollar Baby (Academy Award Winner Be tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t Film, 2004), The Blue Bear and the gym bully are tools to push a) Maggie to the apotheosis and the Ultima t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel te Boon and b) help overcome Morgan Freeman’s challenge. The Complete 188 stage Hero’s Journey and FREE ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust 17 stage sample and other story structure templates can be found at y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ing-creativity.com/">http://managing-creativity.com/ You can also receive a regular, free newsletter b . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de entering your email address at this site. Kal Bishop, MBA ********************************** You are fr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ee to reproduce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Bright Future For Indian Textile Industry For Beginning and Financially Struggling Entrepreneurs - Don't Give Up
|